GlycoMira Therapeutics
PrivateLast Round
Early Funding
Jan 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlycoMira Therapeutics operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. It was founded in 2008.
GlycoMira Therapeutics is a biopharmaceutical company developing a novel class of innate immune system modulators based on naturally occurring polysaccharides for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoMira Therapeutics Comparables
Compare GlycoMira Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cantex Pharmaceuticals | 79% | |
| Enzychem Lifesciences | 79% | |
| Lipella Pharmaceuticals Inc. | 76% |
For institutional investors. Book with your work email.
GlycoMira Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 58% MoM, from 317 to 500.
- May 17, 2026
Monthly visitors grew 66% MoM, from 590 to 979.
For institutional investors. Book with your work email.
GlycoMira Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlycoMira Therapeutics's valuation, stock price, and market status.
Is GlycoMira Therapeutics a public or private company?
GlycoMira Therapeutics is a private company.
What is the current stock price of GlycoMira Therapeutics?
GlycoMira Therapeutics is a private company, so its shares have no public market price. Caplight tracks GlycoMira Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlycoMira Therapeutics worth (valuation)?
Valuation information for GlycoMira Therapeutics is not publicly available.
Can I buy GlycoMira Therapeutics stock?
GlycoMira Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlycoMira Therapeutics's last funding round?
GlycoMira Therapeutics's most recent funding round was Early Funding on January 1, 2025.
Who are the main investors in GlycoMira Therapeutics?
Investor information for GlycoMira Therapeutics is not publicly disclosed.
Will GlycoMira Therapeutics IPO soon?
No public IPO plans have been announced for GlycoMira Therapeutics.
How can I track GlycoMira Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in GlycoMira Therapeutics's shares on secondary markets.